Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Horizontal rectus tenotomy in the treatment of Congenital Nystagmus (CN)

Go back to Resources

Horizontal rectus tenotomy in the treatment of Congenital Nystagmus (CN)

Authors:

Location:

Go back to Resources

After six thousand transplants where are we? The state of pediatric renal transplantation in North America

Go back to Resources

After six thousand transplants where are we? The state of pediatric renal transplantation in North America

Authors:

Location:

Go back to Resources

A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss: AREDS Report No. 9

Go back to Resources

A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss: AREDS Report No. 9

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

A randomized prospective multicenter trial of T-cell antibody induction therapy in pediatric renal transplantation

Go back to Resources

A randomized prospective multicenter trial of T-cell antibody induction therapy in pediatric renal transplantation

Authors:

Location:

Go back to Resources

A Phase II study of two HIV-1 envelope vaccines comparing their immunogenicity in populations at risk for acquiring HIV-1 infection

Go back to Resources

A Phase II study of two HIV-1 envelope vaccines comparing their immunogenicity in populations at risk for acquiring HIV-1 infection

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

A Freedom of Information Act tale

Go back to Resources

A Freedom of Information Act tale

Authors:

Location:

Go back to Resources

Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial 1: Primary outcomes

Go back to Resources

Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial 1: Primary outcomes

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

ROP outcome in infants with prethreshold ROP and SpO2 ›94% in room air

Go back to Resources

ROP outcome in infants with prethreshold ROP and SpO2 ›94% in room air

Authors:

Location:

Go back to Resources

Risk factors associated with age-related macular degeneration. A case-control study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study Report No. 3

Go back to Resources

Risk factors associated with age-related macular degeneration. A case-control study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study Report No. 3

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Review of the COBLT Study Processing Procedures

Go back to Resources

Review of the COBLT Study Processing Procedures

Authors:

Location:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 123
  • Page 124
  • Page 125
  • Page 126
  • Current page 127
  • Page 128
  • Page 129
  • Page 130
  • Page 131
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions